What is open for comment
The North Carolina Board of Pharmacy and North Carolina Medical Board published proposed amendments on October 15. The boards scheduled a public hearing for November 10 at 10 a.m. Eastern in Greensboro. Written comments are due December 14. The boards list April 1, 2027, as the proposed effective date.12
How the proposals implement the law
The underlying 2025 law took effect October 1, 2025 for the practice provisions. It allows clinical pharmacist practitioners to provide services delegated under a written agreement with a site-specific supervising physician. It also allows institutional and group practices to implement site-specific agreements with multiple providers, subject to an oversight policy and evaluation by an appointed supervising physician.4
The proposed rules describe what the written agreement must address, including delegated services and plans for supervision and evaluation. The drafts also propose 25 hours of practice-relevant continuing education each calendar year.23
What practices can review
A practice preparing comments can compare its existing agreements with the draft and identify who signs, who covers when the supervising physician is away, and how changes reach the pharmacy team. Specific examples of where a proposed provision would delay care or complicate oversight can help the boards assess the text before adoption.
Source notes
- N.C. Bd. of Pharmacy, Rulemaking Notices, Amendment to 21 NCAC 46 .3101, Clinical Pharmacist Practitioner (2026).
- Notice of Text, Clinical Pharmacist Practitioner, 41 N.C. Reg. 729–30, 735–36 (Oct. 15, 2026).
- N.C. Med. Bd., Proposed Amendments to 21 N.C. Admin. Code 32T .0101, at 5–6 (2026).
- 2025 N.C. Sess. Laws 37, §§ 7.1, 7.4 (codified in relevant part at N.C. Gen. Stat. §§ 90-18, 90-18.4).